Oncotelic Therapeutics, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Oncotelic Therapeutics, Inc. (OTLC) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $590.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-04-10.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2019-04-10
- Oncotelic Therapeutics, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2018 was $590.00K.
- Oncotelic Therapeutics, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2017 was -$29.21M, a 714.11% decline from fiscal 2016.
- Oncotelic Therapeutics, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2016 was $4.76M, a 10.63% increase from fiscal 2015.
- Oncotelic Therapeutics, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2015 was $4.30M, a 10.91% increase from fiscal 2014.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2018-12-31 | $590.00K 10-K · filed 2019-04-10 | |
| 2017-12-31 | -$29.21M 10-K · filed 2019-04-10 | |
| 2016-12-31 | $4.76M 10-K · filed 2018-04-17 | |
| 2015-12-31 | $4.30M 10-K · filed 2017-03-30 | |
| 2014-12-31 | $3.88M 10-K · filed 2016-03-25 | $3.88M 10-K · filed 2015-03-30 |
| 2013-12-31 | $2.64M 10-K · filed 2015-03-30 | |
| 2012-12-31 | -$195.00K 10-K · filed 2014-03-20 | $195.00K 10-K · filed 2013-03-15 |
| 2011-12-31 | $2.85M 10-K · filed 2013-03-15 |